Zobrazeno 1 - 10
of 277
pro vyhledávání: '"European Medicines Agency – EMA"'
Publikováno v:
Current Oncology, Vol 31, Iss 8, Pp 4443-4454 (2024)
Introduction: Advancements in oncology have revolutionized cancer treatment, with new drugs being approved at different rates worldwide. Our objective was to evaluate the approval of new oncological drugs for solid tumors by the Food and Drug Adminis
Externí odkaz:
https://doaj.org/article/d59daccf2e3440be92bd0c3179eced2e
Publikováno v:
Frontiers in Medicine, Vol 11 (2024)
Externí odkaz:
https://doaj.org/article/9cf8bc6a26284b759665a0fc08719c04
Publikováno v:
JHLT Open, Vol 6, Iss , Pp 100152- (2024)
Pulmonary arterial hypertension is a complex and heterogeneous condition, associated with a considerable diagnostic delay, diminished exercise capacity, and poor outcomes. In pulmonary arterial hypertension, biomarker research has become a subject of
Externí odkaz:
https://doaj.org/article/ebc3d90e3906401b8ede75ce832f4330
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Maria Manuel Teixeira, Fábio Cardoso Borges, Paula Sousa Ferreira, João Rocha, Bruno Sepodes, Carla Torre
Publikováno v:
Frontiers in Medicine, Vol 9 (2022)
IntroductionCancer and corresponding available treatments are associated with substantial symptoms and functional limitations. In this context, collection of patient-reported outcomes (PRO) in clinical trials gained special interest and is recommende
Externí odkaz:
https://doaj.org/article/41b50a2da2264e9d92cbdd6e659e9780
Publikováno v:
Frontiers in Medicine, Vol 9 (2022)
With the implementation of the new EU regulation on in vitro diagnostics (IVDR) in May 2022, notified bodies will be required to assess Companion Diagnostics (CDx). The EMA and national medicines agencies will be consulted on the performance and safe
Externí odkaz:
https://doaj.org/article/c2e08cea09924139807f458c866e210c
Autor:
Olga Potemkina
Publikováno v:
Научно-аналитический вестник Института Европы РАН, Pp 32-38 (2020)
The article deals with numerous initiatives of the EU Commission, both legislative and political, aimed at strengthening the MS coordination in the field of health. Based on the Commission’s recommendations on restrictions of freedom of movement, t
Externí odkaz:
https://doaj.org/article/0fe1e780c9854ef99126afb1cf0ffc72
Autor:
V. Mahler, D. Mentzer, A. Bonertz, A. Muraro, P. Eigenmann, J. Bousquet, S. Halken, O. Pfaar, M. Jutel, U. Wahn, S. Vieths, S. Kaul
Publikováno v:
Clinical and Translational Allergy, Vol 10, Iss 1, Pp 1-7 (2020)
Abstract Concerning development of medicinal products, children belong to a so-called “special population” for which additional legislation applies: Regulation (EC) No 1901/2006 on medicinal products for paediatric use sets up a system of require
Externí odkaz:
https://doaj.org/article/a7b64716ac414b3392b67317faac2d9c
Autor:
Tugba Gulsun, Selma Sahin
Publikováno v:
Medicine Science, Vol 9, Iss 1, Pp 261-4 (2020)
The oral route is the most preferred route for drug administration because of patient compliance. Following oral administration, a drug has to cross several biological barriers before reaching the systemic circulation by transcellular or paracellular
Externí odkaz:
https://doaj.org/article/47f52cb8bba641dfab9cc1dc63420c81
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2021)
Rare diseases are life-threatening or chronically debilitating low-prevalent disorders caused by pathogenic mutations or particular environmental insults. Due to their high complexity and low frequency, important gaps still exist in their prevention,
Externí odkaz:
https://doaj.org/article/fa1374087dac438599641bcb0f83fb43